A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gabor Illei, MD
MedImmune LLC
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
107 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Buenos Aires, Argentina
- Research Site
Ciudad Autonoma de Buenos Aire, Argentina
- Research Site
Ciudad de Buenos Aires, Argentina
- Research Site
La Plata, Argentina
- Research Site
Quilmes, Argentina
- Research Site
San Miguel de Tucumán, Argentina
- Research Site
Curitiba, Brazil
- Research Site
Goiânia, Brazil
- Research Site
Juiz de Fora, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
Salvador, Brazil
- Research Site
São Paulo, Brazil
- Research Site
Plovdiv, Bulgaria
- Research Site
Sofia, Bulgaria
- Research Site
Québec, Quebec, Canada
- Research Site
Sherbrooke, Quebec, Canada
- Research Site
Osorno, Chile
- Research Site
Santiago, Chile
- Research Site
Viña del Mar, Chile
- Research Site
Bordeaux, France
- Research Site
Le Kremlin-Bicêtre, France
- Research Site
Paris, France
- Research Site
Strasbourg, France
- Research Site
Berlin, Germany
- Research Site
Cologne, Germany
- Research Site
Dresden, Germany
- Research Site
Frankfurt, Germany
- Research Site
Kiel, Germany
- Research Site
Leipzig, Germany
- Research Site
Mainz, Germany
- Research Site
Münster, Germany
- Research Site
Regensburg, Germany
- Research Site
Würzburg, Germany
- Research Site
Budapest, Hungary
- Research Site
Debrecen, Hungary
- Research Site
Miskolc, Hungary
- Research Site
Zalaegerszeg, Hungary
- Research Site
Bangalore, India
- Research Site
Secunderabad, India
- Research Site
Brescia, Italy
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2011
- Primary completion
- 14 Nov 2013
- Completion
- 17 Apr 2014
- Last update posted
- 19 Apr 2018
- Registered enrollment
- 834
- Registry id
- NCT01283139
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.